Cytokine concentration in serum of lupus erythematosus patients: The effect on acute phase response

Journal of Medicine

Volumn 28, Issue 1-2, 1997, Pages 99-107

  Lacki, Jan K ^a,b   Leszczynski, Piotr ^b   Kelemen, Judit ^a   Müller, Wolfgang ^a   Mackiewicz, Stefan H ^b  

^a Hochrhein Inst Rheumatism Res P   (Germany)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Acute phase response; Cytokines; Systemic lupus erythematosus

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; C REACTIVE PROTEIN; CILIARY NEUROTROPHIC FACTOR; CYTOKINE; GAMMA INTERFERON; INTERFERON; INTERLEUKIN 10; ONCOSTATIN M; OROSOMUCOID; TUMOR NECROSIS FACTOR;

ARTICLE; B LYMPHOCYTE ACTIVATION; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; IMMUNOREGULATION; KERATINOCYTE; LUPUS ERYTHEMATOSUS; PROTEIN ANALYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

ACUTE-PHASE REACTION; ADOLESCENT; ADULT; ALPHA 1-ANTICHYMOTRYPSIN; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-6; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; OROSOMUCOID; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030850755     PISSN: 00257850     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Al-Janadi, M., Al Balla, S., Al Dalaan, A. and Raziuddin, S. (1993).: Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases. J. Clin. Immunol. 13: 58-67.
2. Defrance, T., Vanbervliet, B., Briere, F., Durand, I., Rousset, F. and Bancherrau, J. (1992).: Interleukin-10 and transforming growth factor b cooperate to induce anti CD40 activated naive human B cells to secrete immnoglobulin A. J. Exp. Med. 175: 671-682.
3. 1 clones. J. Exp. Med. 170: 2081-2088.
4. Fiorentino, D.F., Zlotnik, A., Mosmann, T.R., Howard, M. and O'Garra, A. (1991).: IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147: 3815-3822.
5. Gabay, C., Roux-Lombard, P., de Moerloose, P., Dayer, J.M., Vischer, T. and Guerne P.A. (1993).: Absence of correlation between interleukin-6 and C-reactive protein blood levels in systemic lupus erythematosus compared with rheumatoid arthritis. J. Rheumatol. 20: 815-821.
6. Kim, T., Kanayama, Y., Negoro, N., Okamura, M., Takeda, T. and Inoue, T. (1987).: Serum levels of interferons in patients with systemic lupus erythematosus. Clin. Exp. Immunol. 70: 562-566.
7. Klinman, D.M., Steinberg, A.D. (1995).: Inquiry into murine and human lupus. Immunol. Rev. 144: 157-193.
8. Lin, H., Mosmann, T.R., Guilbert, L., Tuntipopipat, S. and Wegmann T.G. (1993).: Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J. Immunol. 151: 4562-4573.
9. Linker-Israeli, M. (1992).: Cytokine abnormalities in human lupus. Clin. Immunol. Immunopathol. 63: 10-12.
10. Linker-Israeli, M., Deans, R.J., Wallace, D.J., Prehn, J., Ozeri-Chen, T. and Klinenberg, J.R. (1991).: Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. J. Immunol. 147: 117-123.
11. Llorente, L., Richaud-Patin, Y., Fior, R. (1994).: In vivo production of IL-10 by non-T cells in RA, Sjögren syndrome, and SLE. Arthritis Rheum. 37: 1647-1655.
12. Llorente, L., Richaud-Patin, Y. and Wijdenes, J. (1993).: Spontaneous production of IL-10 by B lymphocytes in SLE. Eur. Cytokine Netw. 4: 421-430.
13. Mackiewicz, A., Pawlowski, T., Mackiewicz-Pawlowska, A., Wiktorowicz, K. and Mackiewicz, S. (1987).: Microheterogeneity of alpha-1-acid glycoprotein as indicator of rheumatoid arthritis activity. Clin. Chim. Acta 163: 185-190.
14. Maury, C.P. and Teppo, A.M. (1989).: Tumor necrosis factor in the serum of patients with systemic lupus erythematosus. Arthritis Rheum. 32: 146-150.
15. Merville, P., Rousset, F., Banchereau, J., Klein, B. and Bataille, R. (1992).: Serum interleukin-10 in early stage multiple myeloma. Lancet 340: 1544-1555.
16. Pecanha, L.M.T., Snapper, C.M., Lees, A., and Mond, J.J. (1992).: Lymphokine control of type 2 antigen response: IL-10 inhibits IL-5 but not IL-2 induced Ig secretion by T-cell independent antigens. J. Immunol. 148: 3427-3432.
17. Steinberg, A.D., Gourley, M.F., Klinman, D.M., Tsokos, G.C., Scott, D.E. and Kreig, A.M. (1991).: Systemic lupus erythematosus. Ann. Intern. Med. 115: 548-559.
18. Sturfelt, G. (1984).: Complement components, complement activation and acute phase response in systemic lupus erythematosus. Int. Arch. Allergy. Appl. Immunol. 75: 75-83.
19. Swaak, A.J.G., van Rooyen, A. and Aarden L.A. (1989).: Interleukin-6 (IL-6) and acute phase proteins in the disease course of patients with systemic lupus erythematosus. Rheumatol. Int. 8: 263-268.
20. Tan, E.M., Cohen, A.S., Fries, J.F., Masi, A.T., AcShane, D.J., Rothfield, N.F., Schaller, J.G., Talal, N. and Winchester, R.J. (1982).: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25: 1271-1277.
21. Vieira, P., de Waal-Malefyt, R., Dang, M.N., Johnson, K.E. and Kastelein, R. (1991).: Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: Homology to Epstein-Barr virus open reading frame BCRFI. Proc. Natl. Acad. Sci. USA. 88: 1172-79.